897 related articles for article (PubMed ID: 23859843)
1. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
[TBL] [Abstract][Full Text] [Related]
3. Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: a cohort study from 2009 to 2011.
Tacken MA; Jansen B; Mulder J; Visscher S; Heijnen ML; Campbell SM; Braspenning JC
Vaccine; 2013 Jan; 31(6):900-5. PubMed ID: 23246546
[TBL] [Abstract][Full Text] [Related]
4. Behavioral change with influenza vaccination: factors influencing increased uptake of the pandemic H1N1 versus seasonal influenza vaccine in health care personnel.
Kraut A; Graff L; McLean D
Vaccine; 2011 Oct; 29(46):8357-63. PubMed ID: 21888939
[TBL] [Abstract][Full Text] [Related]
5. Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol.
Hirsch A; Katz MA; Laufer Peretz A; Greenberg D; Wendlandt R; Shemer Avni Y; Newes-Adeyi G; Gofer I; Leventer-Roberts M; Davidovitch N; Rosenthal A; Gur-Arie R; Hertz T; Glatman-Freedman A; Monto AS; Azziz-Baumgartner E; Ferdinands JM; Martin ET; Malosh RE; Neyra Quijandría JM; Levine M; Campbell W; Balicer R; Thompson MG;
BMC Infect Dis; 2018 Nov; 18(1):550. PubMed ID: 30400834
[TBL] [Abstract][Full Text] [Related]
6. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
[TBL] [Abstract][Full Text] [Related]
7. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
[TBL] [Abstract][Full Text] [Related]
8. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of 2009 pandemic influenza A virus subtype H1N1 among Kenyans aged 2 months to 18 years, 2009-2010.
Wong KK; Bulimo WD; Magana J; Achilla RA; Schwarcz SK; Simwa M; Majanja JM; Wadegu MO; Osuna FA; Mukunzi SO; Mwangi JK; Wangui JM; Muthoni JN; Njiri JO; Obura BD; Opot BH; Mitei KK; Barani J; Lifumo S; Schnabel DC
J Infect Dis; 2012 Dec; 206 Suppl 1():S68-73. PubMed ID: 23169975
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.
Song JY; Cheong HJ; Heo JY; Noh JY; Choi WS; Park DW; Lee J; Jeong HW; Kee SY; Kim WJ
Vaccine; 2011 Feb; 29(7):1395-8. PubMed ID: 21199701
[TBL] [Abstract][Full Text] [Related]
11. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
12. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
[TBL] [Abstract][Full Text] [Related]
14. Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.
Hellenbrand W; Jorgensen P; Schweiger B; Falkenhorst G; Nachtnebel M; Greutélaers B; Traeder C; Wichmann O
BMC Infect Dis; 2012 May; 12():127. PubMed ID: 22650369
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of pandemic influenza A (H1N1) 2009 vaccine in healthcare workers at a university hospital in Japan.
Igari H; Watanabe A; Chiba H; Shoji K; Segawa S; Nakamura Y; Watanabe M; Suzuki K; Sato T
Jpn J Infect Dis; 2011; 64(3):177-82. PubMed ID: 21617299
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and sensitivity analysis of the effectiveness of unadjuvanted A(H1N1)pdm09 vaccine in hospital workers using multi-center cohort study in Korea.
Lim J; Choi B; Kim J; Kim J; Kim C; Park J; Yoon H; Hong S; Seo J; Ki M
Vaccine; 2013 May; 31(19):2381-6. PubMed ID: 23499597
[TBL] [Abstract][Full Text] [Related]
17. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
18. High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand.
Kiertiburanakul S; Malathum K; Watcharananan SP; Bunupuradah P; Piebpien P; Rujiraviroj U; Likitsinsipon W; Apivanich S; Kehachindawat P; Burakitcharoen R; Leelaudomlipi S; Wananukul W
Am J Infect Control; 2011 Aug; 39(6):525-8. PubMed ID: 21612842
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
[TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
